PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Insilico Medicine showcases at WHX 2026: Connecting the Middle East with global partners to accelerate translational research

2026-02-06
(Press-News.org) Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced its participation in the World Health Expo 2026 (WHX 2026), held from February 9–12 at the Dubai Exhibition Centre, UAE. As one of the premier global healthcare exhibitions, WHX 2026 serves as a high-impact platform for international healthcare enterprises, research institutions, and investors to explore digital health, biomedical innovation, and life sciences in the Middle East and beyond.

Insilico Medicine, in partnership with the Emirates Drug Establishment (EDE), will present its latest breakthroughs in AI-driven drug discovery at a joint booth. Interested attendees can find the team at South Hall, Booth S19J30 (Emirates Health).

Further reinforcing its leadership in the field, Dr. Alex Aliper, Co-founder and President of Insilico Medicine, is scheduled to speak at the "Frontier Stage: Biotechnology & Life Sciences" forum. He will join a panel discussion titled "Translational Research and Innovation: From Regional to Global" on February 9 at 3:10 PM local time. Dr. Aliper, alongside regional researchers and international biotech experts, will contribute to the discussion on key topics, including how to connect local research institutions with global biotech leaders, improve translational pathways from the laboratory to the clinic, and attract international investment to regional Research & Development ecosystems.

Since February 2023, Insilico Medicine has operated an AI and quantum computing drug discovery R&D center in Abu Dhabi. As one of the largest AI-driven drug discovery hubs in the Middle East, the center is dedicated to advancing drug discovery programs and the development of Insilico’s Pharma.AI platform, while fostering cross-disciplinary innovation at the intersection of artificial intelligence and life sciences.

The R&D center has established close and in-depth collaborations with leading UAE academic institutions, including Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), Khalifa University, New York University Abu Dhabi (NYU Abu Dhabi), and United Arab Emirates University. Through joint research initiatives, talent development programs, and academic exchange platforms, Insilico Medicine is actively contributing to the region’s innovation ecosystem and continues to generate research outcomes with global impact.

These strategic efforts underscore Insilico Medicine’s commitment to advancing scientific progress across the Middle East and beyond, strengthening leadership in AI-enabled biotechnology, and sustaining long-term investment in a diverse, international talent base and an open, collaborative innovative environment.

 

About World Health Expo Dubai (WHX Dubai)
World Health Expo Dubai (WHX Dubai), formerly known as Arab Health, is a global meeting place for the healthcare community dedicated to advancing healthcare worldwide. For more than 50 years, it has served as a key platform for professionals driving the industry forward. As part of one of the world’s largest international healthcare exhibition networks, WHX Dubai connects attendees with the people, products, and ideas shaping healthcare today. Over four days, thousands of professionals come together to build meaningful connections and deliver tangible outcomes.

 

About Insilico Medicine

Insilico Medicine is a pioneering global biotechnology company dedicated to integrating artificial intelligence and automation technologies to accelerate drug discovery, drive innovation in the life sciences, and extend healthy longevity to people on the planet. The company was listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2025, under the stock code 03696.HK.

By integrating AI and automation technologies and deep in-house drug discovery capabilities, Insilico is delivering innovative drug solutions for unmet needs including fibrosis, oncology, immunology, pain, and obesity and metabolic disorders. Additionally, Insilico extends the reach of Pharma.AI across diverse industries, such as advanced materials, agriculture, nutritional products and veterinary medicine. For more information, please visit www.insilico.com

END


ELSE PRESS RELEASES FROM THIS DATE:

From rice fields to fresh air: Transforming agricultural waste into a shield against indoor pollution

2026-02-06
Formaldehyde is a common but unwelcome guest in many modern homes, leaking silently from furniture, flooring, and household products. While this colorless gas is a known respiratory irritant, cleaning it out of the air usually requires expensive or energy-heavy technology. Now, a research team from Vietnam National University has found a clever way to turn agricultural waste into a high-tech filter that breathes new life into indoor spaces. In a study published in Carbon Research, the team describes how they successfully ...

University of Houston study offers potential new targets to identify, remediate dyslexia

2026-02-06
A University of Houston psychology professor is challenging the notion that dyslexia, or specific reading disorder, stems from a single faulty gene in the brain, suggesting instead that it is caused by an overall brain network vulnerability. The insight reshapes understanding of one of the world’s most common learning disorders, which affects up to 20% of the world’s population—nearly 780 million people who face lifelong challenges with reading.  Using computers and large biology databases, Elena Grigorenko, Hugh Roy and Lillie Cranz Cullen ...

Scientists uncover hidden role of microalgae in spreading antibiotic resistance in waterways

2026-02-06
Antibiotic resistance is widely recognized as one of the greatest global public health threats, but scientists are now uncovering an unexpected contributor to the problem living quietly in rivers, lakes, and coastal waters. A new review highlights how microalgae, microscopic photosynthetic organisms that support aquatic food webs, may also help concentrate and spread antibiotic resistance genes in natural water environments. The study, published in the journal Biocontaminant, synthesizes emerging research showing that microalgae ...

Turning orange waste into powerful water-cleaning material

2026-02-06
Researchers have developed an environmentally friendly way to transform discarded orange peels into a highly efficient material that can remove toxic dyes from wastewater, offering a sustainable solution to two growing global challenges: agricultural waste management and water pollution. Industrial dye pollution is a major environmental problem worldwide. Each year, more than 700,000 tons of synthetic dyes are produced, and a significant portion enters waterways due to incomplete treatment. Even at low concentrations, dyes can discolor water, block sunlight essential for aquatic life, and produce harmful compounds that pose risks to human and ecosystem ...

Papadelis to lead new pediatric brain research center

2026-02-06
Christos Papadelis, a pioneering researcher at The University of Texas at Arlington and leader in the Jane and John Justin Institute for Mind Health at Cook Children’s Health Care System, will serve as the founding director of the UTA Pediatric Brain Health and Neurosciences Center. The center links clinical and academic communities and bridges the gap between scientific discovery and patient care. Since 2015, UTA has earned the prestigious R1 designation from the Carnegie Classifications of ...

Power of tiny molecular 'flycatcher' surprises through disorder

2026-02-06
For decades, scientists assumed that order drives efficiency. Yet in the bustling machinery of mitochondria — the organelles that crank out adenosine triphosphate (ATP), the universal “energy currency” of cells — one of the most enigmatic components is a protein that appears anything but orderly. ATP powers nearly every biological task, from muscle contraction to neural signaling, by breaking high-energy phosphate bonds and being continually recharged through metabolism. This life-sustaining energy cycle depends on highly coordinated flows of electrons within respiratory supercomplexes. ...

Before crisis strikes — smartwatch tracks triggers for opioid misuse

2026-02-06
Opioid overdoses continue to take a devastating toll across the United States. According to the U.S. Centers for Disease Control and Prevention (CDC), in 2023, the nation recorded roughly 105,000 drug overdose deaths overall, with nearly 80,000 deaths involving opioids. Worldwide, opioids are also responsible for the majority of drug-related deaths. A University of California San Diego study is working on a potentially life-saving measure that may be as simple as strapping on a smartwatch. Researchers have ...

Statins do not cause the majority of side effects listed in package leaflets

2026-02-06
Cardiovascular disease results in around 20 million deaths worldwide and causes around a quarter of all deaths in the UK. Statins are highly effective drugs that lower LDL (“bad”) cholesterol levels and have been repeatedly proven to reduce the risk of cardiovascular disease. However, there have been concerns about possible side effects. The researchers gathered data from 23 large-scale randomised studies from the Cholesterol Treatment Trialists’ Collaboration: 123,940 participants in 19 large-scale clinical trials comparing the effects of statin therapies against a placebo (or dummy tablet), and 30,724 participants in four trials comparing more intensive versus less intensive ...

UC Riverside doctoral student awarded prestigious DOE fellowship

2026-02-05
RIVERSIDE, Calif. -- Ryan Milton, a fourth-year doctoral student in nuclear physics at UC Riverside, has been awarded a U.S. Department of Energy’s Office of Science Graduate Student Research (SCGSR) Fellowship. The fellowship, which provides a $3,600 monthly stipend for one year, will support his research at the SLAC National Accelerator Laboratory, part of Stanford University. “My research focuses on developing and deploying AI tools to understand the behavior of protons and neutrons in nuclei,” Milton said. “Each proton and neutron is made of quarks, but we still don’t fully understand ...

UMD team finds E. coli, other pathogens in Potomac River after sewage spill

2026-02-05
COLLEGE PARK, Md. – Following one of the largest sewage spills in U.S. history, University of Maryland researchers have detected high levels of fecal-related bacteria and disease-causing pathogens in the Potomac River, raising urgent public health concerns and underscoring the risks posed by aging sewer infrastructure.  Water sample results collected at the site by researchers show high levels of E. coli are present along with Staphylococcus aureus (the bacteria that causes Staph infections). An antibiotic-resistant strain of S. aureus, MRSA, was also identified at the site of the sewage overflow. “People coming into contact with the impacted ...

LAST 30 PRESS RELEASES:

Study: Blocking a key protein may create novel form of stress in cancer cells and re-sensitize chemo-resistant tumors

HRT via skin is best treatment for low bone density in women whose periods have stopped due to anorexia or exercise, says study

Insilico Medicine showcases at WHX 2026: Connecting the Middle East with global partners to accelerate translational research

From rice fields to fresh air: Transforming agricultural waste into a shield against indoor pollution

University of Houston study offers potential new targets to identify, remediate dyslexia

Scientists uncover hidden role of microalgae in spreading antibiotic resistance in waterways

Turning orange waste into powerful water-cleaning material

Papadelis to lead new pediatric brain research center

Power of tiny molecular 'flycatcher' surprises through disorder

Before crisis strikes — smartwatch tracks triggers for opioid misuse

Statins do not cause the majority of side effects listed in package leaflets

UC Riverside doctoral student awarded prestigious DOE fellowship

UMD team finds E. coli, other pathogens in Potomac River after sewage spill

New vaccine platform promotes rare protective B cells

Apes share human ability to imagine

Major step toward a quantum-secure internet demonstrated over city-scale distance

Increasing toxicity trends impede progress in global pesticide reduction commitments

Methane jump wasn’t just emissions — the atmosphere (temporarily) stopped breaking it down

Flexible governance for biological data is needed to reduce AI’s biosecurity risks

Increasing pesticide toxicity threatens UN goal of global biodiversity protection by 2030

How “invisible” vaccine scaffolding boosts HIV immune response

Study reveals the extent of rare earthquakes in deep layer below Earth’s crust

Boston College scientists help explain why methane spiked in the early 2020s

Penn Nursing study identifies key predictors for chronic opioid use following surgery

KTU researcher’s study: Why Nobel Prize-level materials have yet to reach industry

Research spotlight: Interplay of hormonal contraceptive use, stress and cardiovascular risk in women

Pennington Biomedical’s Dr. Catherine Prater awarded postdoctoral fellowship from the American Heart Association

AI agents debate more effectively when given personalities and the ability to interrupt

Tenecteplase for acute non–large vessel occlusion 4.5 to 24 hours after ischemic stroke

Immune 'hijacking' predicts cancer evolution

[Press-News.org] Insilico Medicine showcases at WHX 2026: Connecting the Middle East with global partners to accelerate translational research